Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Alpha-GPC wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
6 of 6 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (2)
Outcomes where both Alpha-GPC and Noopept have evidence — compare verdict strength side-by-side.
300-600mg daily
Morning for cognitive enhancement, 30-60 min before workout for performance
Alpha-GPC 50% powder or capsules
10-30mg daily in divided doses
Morning and early afternoon, Divided into 2-3 doses, Sublingual for faster onset
Noopept powder (sublingual) or capsules
1-2 hours
2-4 weeks
Acute
Same day
1-2 weeks
Acute to 1 week
Ongoing
With higher doses
L-Alpha-Glycerylphosphorylcholine (L-α-GPC): A Comprehensive Review of Its Preparation Techniques and Versatile Biological Effects
Journal of food science (2025) · Systematic review
Due to its high choline content (41% by weight) and ability to cross the blood-brain barrier, GPC is considered one of the most utilized sources of choline.
Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis
Journal of Alzheimer's disease : JAD (2023) · Meta analysis · n=1326
We found significant effects of α-GPC in combination with donepezil on cognition [4 RCTs, mean difference (MD):1.72, 95% confidence interval (CI): 0.20 to 3.25], functional outcomes [3 RCTs, MD:0.79, 95% CI: 0.34 to 1.23], and behavioral outcomes [4 RCTs; MD: -7.61, 95% CI: -10.31 to -4.91].
Revisiting choline alphoscerate profile: a new, perspective, role in dementia?
The International journal of neuroscience (2013) · Systematic review
Choline alphoscerate (alpha-glyceryl-phosphorylcholine, alpha-GPC) is a semisynthetic derivative of phosphatidylcholine with central parasympathomimetic action.
Novel Technologies for Dipeptide Drugs Design and their Implantation
Current pharmaceutical design (2018) · Systematic review
The latter usually corresponds to a beta-turn of some regulatory peptide.
Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation
Journal of biomedical science (2014) · Observational
Taken together, these data provide evidence that novel cognitive enhancer noopept protects PC12 cell against deleterious actions of Aβ through inhibiting the oxidative damage and calcium overload as well as suppressing the mitochondrial apoptotic pathway.
Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin
Neuroscience and behavioral physiology (2009) · Observational
Clinical trial examining Noopept efficacy
Based on RCTs showing cognitive improvements in healthy adults and dementia patients. Effect sizes were modest and some studies used combination therapy. Higher doses associated with increased headache risk.
Based on RCT with n=60 showing MMSE improvements after 2 months. Most studies lack placebo controls and have small sample sizes. Effectiveness may be overestimated due to study limitations.
AI-estimated from published studies. Interpret as directional guidance.
Alpha-GPC has a higher evidence score (7/10 vs 4/10) and wins in 2 of 3 categories.
For sharpen focus, Alpha-GPC has a higher relevance score (80 vs 75).
No known interactions between Alpha-GPC and Noopept have been documented in our database. However, always consult a healthcare provider before combining supplements.